Quality of life in schizophrenia: long-term follow-up in 362 chronic Spanish schizophrenic outpatients undergoing risperidone maintenance treatment

By Bobes J.   Gutierrez M.   Gibert J.   Gonzalez M.   Herraiz L.   Fernandez A.  

European Psychiatry, Vol. 13, Iss. 3, 1998-05 ,pp. : 158-163

Elsevier

Access to resources Recommend Favorite

Long-term assessment of the efficacy and tolerability of risperidone in early schizophrenia: An international multicenter study

By Rybakowski Janusz K.   Jarema Marek  

International Journal of Psychiatry in Clinical Practice, Vol. 8, Iss. 3, 2004-09 ,pp. : 147-152

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study

By Lee Phil   Eung Kim Chul   Yoon Kim Chang   Lin Wei-Wen   Habil Hussain   Dyachkova Yulia   Mcbride Margaret   Dossenbach Martin  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 215-227

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Efficacy and safety of long-term risperidone treatment

By Hotujac L.J.   Šagud M  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 4, 2002-12 ,pp. : 193-197

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The health economic implications of treatment with quetiapine: an audit of long-term treatment for patients with chronic schizophrenia

By Lynch J.   Morrison J.   Graves N.   Meddis D.   Drummond M.F.   Hellewell J.S.E.  

European Psychiatry, Vol. 16, Iss. 5, 2001-08 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite